Cargando…
Adoptive B cell therapy for chronic viral infection
T cell-based therapies have been widely explored for the treatment of cancer and chronic infection, but B cell-based therapies have remained largely unexplored. To study the effect of B cell therapy, we adoptively transferred virus-specific B cells into mice that were chronically infected with lymph...
Autores principales: | Chung, Young Rock, Dangi, Tanushree, Palacio, Nicole, Sanchez, Sarah, Penaloza-MacMaster, Pablo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9361846/ https://www.ncbi.nlm.nih.gov/pubmed/35958615 http://dx.doi.org/10.3389/fimmu.2022.908707 |
Ejemplares similares
-
Early type I IFN blockade improves the efficacy of viral vaccines
por: Palacio, Nicole, et al.
Publicado: (2020) -
Limiting the priming dose of a SARS CoV-2 vaccine improves virus-specific immunity
por: Sanchez, Sarah, et al.
Publicado: (2021) -
TLR4 signaling improves PD-1 blockade therapy during chronic viral infection
por: Wang, Yidan, et al.
Publicado: (2019) -
Combining spike- and nucleocapsid-based vaccines improves distal control of SARS-CoV-2
por: Dangi, Tanushree, et al.
Publicado: (2021) -
Pre-existing immunity modulates responses to mRNA boosters
por: Dangi, Tanushree, et al.
Publicado: (2022)